trans-Sialidase and cruzipain are important virulence factors from Trypanosoma cruzi, the etiological agent of Chagas disease,
that have highly antigenic domains in their structure and were reported
as potential tools for diagnosis of the illness. The aim of the present
study is to assess the possibility of using cruzipain and the catalytic
domain of trans-sialidase in a Surface Plasmon Resonance-based
immunosensor for the diagnosis of chronic Chagas disease. Immunoassays
carried out with canine sera verified that cruzipain allows the detection
of anti-Trypanosoma cruzi antibodies whereas recombinant trans-sialidase did not yield specific detections, due to
the high dilutions of serum used in the immunoassays that hinder the
possibility to sense the specific low titer antibodies. The developed
cruzipain-based biosensor, whose price per assay is comparable to
a commercial enzyme-linked immunosorbent assay (ELISA), was successfully
applied for the rapid quantification of specific antibodies against Trypanosoma cruzi in fresh human sera showing an excellent
agreement with ELISA.
Plant and herbal essential oils (EOs) offer a wide range of pharmacological actions that include anticancer effects. Here, we evaluated the cytotoxic activity of EO from Lippia alba (chemotype linalool), L. alba (chemotype dihydrocarvone, LaDEO), Clinopodium nepeta (L.) Kuntze (CnEO), Eucalyptus globulus, Origanum × paniculatum, Mentha × piperita, Mentha arvensis L., and Rosmarinus officinalis L. against human lung (A549) and colon (HCT-116) cancer cells. The cells were treated with increasing EO concentrations (0–500 µL/L) for 24 h, and cytotoxic activity was assessed. LaDEO and CnEO were the most potent EOs evaluated (IC50 range, 145–275 µL/L). The gas chromatography–mass spectrometry method was used to determine their composition. Considering EO limitations as therapeutic agents (poor water solubility, volatilization, and oxidation), we evaluated whether LaDEO and CnEO encapsulation into solid lipid nanoparticles (SLN/EO) enhanced their anticancer activity. Highly stable spherical SLN/LaDEO and SLN/CnEO SLN/EO were obtained, with a mean diameter of 140–150 nm, narrow size dispersion, and Z potential around −5mV. EO encapsulation strongly increased their anticancer activity, particularly in A549 cells exposed to SLN/CnEO (IC50 = 66 µL/L CnEO). The physicochemical characterization, biosafety, and anticancer mechanisms of SLN/CnEO were also evaluated in A549 cells. SLN/CnEO containing 97 ± 1% CnEO was highly stable for up to 6 months. An increased in vitro CnEO release from SLN at an acidic pH (endolysosomal compartment) was observed. SLN/CnEO proved to be safe against blood components and non-toxic for normal WI-38 cells at therapeutic concentrations. SLN/CnEO substantially enhanced A549 cell death and cell migration inhibition compared with free CnEO.
Liver inflammation represents a major clinical problem in a wide range of pathologies. Among the strategies to prevent liver failure, dexamethasone (DXM) has been widely used to suppress inflammatory responses. The use of nanocarriers for encapsulation and sustained release of glucocorticoids to liver cells could provide a solution to prevent severe side effects associated with systemic delivery as the conventional treatment regime. Here we describe a nanostructured lipid carrier developed to efficiently encapsulate and release DXM. This nano-formulation proved to be stable over time, did not interact in vitro with plasma opsonins, and was well tolerated by primary non-parenchymal liver cells (NPCs). Released DXM preserved its pharmacological activity, as evidenced by inducing robust anti-inflammatory responses in NPCs. Taken together, nanostructured lipid carriers may constitute a reliable platform for the delivery of DXM to treat pathologies associated with chronic liver inflammation.
Plasmonic metal nanoparticles
(NPs) can be used as enhancers of
the efficiency of standard photosensitizers (PSs) in photodynamic
therapy (PDT). Protein corona, the adsorption layer that forms spontaneously
around NPs once in contact with biological fluids, determines to a
great extent the efficiency of PDT. In this work, we explore the possibility
that pectin-coated Au NPs (Au@Pec NPs) could act as adjuvants in riboflavin
(Rf)-based PDT by comparing the photodamage in HeLa cells cultured
in the presence and in the absence of the NPs. Moreover, we investigate
the impact that the preincubation of Rf and Au@Pec NPs (or Ag@Pec
NPs) at two very different serum concentrations could have on cell’s
photodamage. Because reactive oxygen species (ROS) precursors are
the excited states of the PS, the effect of proteins on the photophysics
of Rf and Rf/plasmonic NPs was studied by transient absorption experiments.
The beneficial effect of Au@Pec NPs in Rf-based PDT on HeLa cells
cultured under standard serum conditions was demonstrated for the
first time. However, the preincubation of Rf and Au@Pec NPs (or Ag@Pec
NPs) with serum has undesirable results regarding the enhancement
of Rf-based PDT. In this sense, we also verified that more concentrated
protein conditions result in lower amounts of the triplet excited
state of Rf and thus an expected lower production of ROS, which are
the key elements for PDT’s efficacy. These findings point out
the relevance of serum concentration in the design of
in vitro
cell culture experiments carried out to determine the best way to
combine and use potential sensitizers with plasmonic NPs to develop
more effective PDTs.
The development of drug carriers based in lipid nanoparticles (LNPs) aims toward the synthesis of non-toxic multifunctional nanovehicles that can bypass the immune system and allow specific site targeting, controlled release and complete degradation of the carrier components. Among label free techniques, Surface Plasmon Resonance (SPR) biosensing is a versatile tool to study LNPs in the field of nanotherapeutics research. SPR, widely used for the analysis of molecular interactions, is based on the immobilization of one of the interacting partners to the sensor surface, which can be easily achieved in the case of LNPs by hydrophobic attachment onto commercial lipid- capture sensor chips. In the last years SPR technology has emerged as an interesting strategy for studying molecular aspects of drug delivery that determines the efficacy of the nanotherapeutical such as LNPs' interactions with biological targets, with serum proteins and with tumor extracelullar matrix. Moreover, SPR has contributed to the obtention and characterization of LNPs, gathering information about the interplay between components of the formulations, their response to organic molecules and, more recently, the quantification and molecular characterization of exosomes. By the combination of available sensor platforms, assay quickness and straight forward platform adaptation for new carrier systems, SPR is becoming a high throughput technique for LNPs' characterization and analysis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.